Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Celldex Therapeutics and Neostem

Continue Reading

Number of Companies Paying Special Dividend Rising Rapidly in 2012 as Dividend Tax Increase Looms

Five Star Equities Provides Stock Research on Bristol Myers Squibb and Pfizer

Continue Reading

Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Five Star Equities Provides Stock Research on Neuralstem and Cyclacel Pharmaceuticals

Continue Reading

Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on StemCells and Aastrom Biosciences

Continue Reading

Special Dividend Payments Increase Fourfold in 2012 as Companies Look to Avoid Upcoming Dividend Tax Increase

Five Star Equities Provides Stock Research on Health Care REIT and R.R. Donnelley & Sons

Continue Reading

Amount of Special Dividend Payments in 2012 Currently Four Times the Amount Seen in 2011

Five Star Equities Provides Stock Research on Ameren and Pepco Holdings

Continue Reading

The Amount of Companies Paying Special Dividends in 2012 Is Four Times the Pace of 2011

Five Star Equities Provides Stock Research on Verizon and CenturyLink

Continue Reading

Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Halozyme Therapeutics and Merrimack Pharmaceuticals

Continue Reading

Number of Companies Paying Special Dividend Rising Rapidly in 2012 as Dividend Tax Increase Looms

Five Star Equities Provides Stock Research on Lockheed Martin and Pitney Bowes

Continue Reading

High Dividend Paying Companies Losing Luster Among Investors as Dividend Tax Rate Set to Increase

Five Star Equities Provides Stock Research on Exelon and FirstEnergy

Continue Reading